Blosozumab, CAS 1132758-87-2

Product Description: Blosozumab (LY2541546) is an anti-Human sclerostin (SOST) antibody inhibitor. Blosozumab stimulates bone formation and reduces bone resorption. Blosozumab can be used in the research of Osteoporosis[1][2].

Formula: N/A

References: [1]Robert R Recker, et al. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density. J Bone Miner Res. 2015 Feb;30(2):216-24. /[2]Daniel G Rudmann, et al. Rat-specific decreases in platelet count caused by a humanized monoclonal antibody against sclerostin. Toxicol Sci. 2012 Feb;125(2):586-94.

CAS Number: 1132758-87-2

Molecular Weight: N/A

Compound Purity: 98.20

Research Area: Others

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99186-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99186-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK